Market Indices
Sector Heatmap
NVCR — NovoCure Limited Ordinary Shares
NasdaqNovoCure Limited Ordinary Shares
- O
- 15.27
- H
- 15.88
- L
- 14.90
- V
- 1.75M
NVCR — Latest News & Headlines
13 StoriesNVCR Stock Gains After Novocure Announces Positive Topline Results In Metastatic Pancreatic Cancer Therapy Trial - Stocktwits
NVCR Stock Gains After Novocure Announces Positive Topline Results In Metastatic Pancreatic Cancer Therapy Trial Stocktwits
A results call is set for 8 a.m. Oct. 29, when Novocure will discuss third-quarter results. - Stock Titan
A results call is set for 8 a.m. Oct. 29, when Novocure will discuss third-quarter results. Stock Titan
Novocure Stock Price Forecast. Should You Buy NVCR? - StockInvest.us
Novocure Stock Price Forecast. Should You Buy NVCR? StockInvest.us
NVCR Oct 2026 19.000 call (NVCR261016C00019000) Interactive Stock Chart - Yahoo! Finance Canada
NVCR Oct 2026 19.000 call (NVCR261016C00019000) Interactive Stock Chart Yahoo! Finance Canada
Why NVCR Stock Is Surging Nearly 30% In Overnight Trading - Stocktwits
Why NVCR Stock Is Surging Nearly 30% In Overnight Trading Stocktwits
Responsive Playbooks and the NVCR Inflection - Stock Traders Daily
Responsive Playbooks and the NVCR Inflection Stock Traders Daily
Is NovoCure (NVCR) Undervalued On TTFields Validation And Board Change? - Simply Wall Street
Is NovoCure (NVCR) Undervalued On TTFields Validation And Board Change? Simply Wall Street
Japan approves a wearable device to use with chemo for advanced pancreatic cancer. - Stock Titan
Japan approves a wearable device to use with chemo for advanced pancreatic cancer. Stock Titan
NVCR Oct 2026 18.000 call (NVCR261016C00018000) Interactive Stock Chart - Yahoo! Finance Canada
NVCR Oct 2026 18.000 call (NVCR261016C00018000) Interactive Stock Chart Yahoo! Finance Canada
Why Did CSX, UNP, NVCR Stocks Surge To 52-Week Highs Today? - Stocktwits
Why Did CSX, UNP, NVCR Stocks Surge To 52-Week Highs Today? Stocktwits
NovoCure (NVDA) Could Be 69% Undervalued After Japan Pancreatic Cancer Approval - Simply Wall Street
NovoCure (NVDA) Could Be 69% Undervalued After Japan Pancreatic Cancer Approval Simply Wall Street
Novocure stock heads toward October 29 results after Japan approval - AD HOC NEWS
Novocure stock heads toward October 29 results after Japan approval AD HOC NEWS
NovoCure stock gets Japan approval for Optune Pax - AD HOC NEWS
NovoCure stock gets Japan approval for Optune Pax AD HOC NEWS